Aliskiren inhibits atherosclerosis development and improves plaque stability in APOEM*3Leiden.CETP transgenic mice with or without treatment with atorvastatin
Author(s):
Kuhnast, S.; Hoorn, J.W.A. van der; Hoek, A.M. van den; Havekes, L.M.; Liau, G.; Jukema, J.W. (0000-0002-3246-8359); Princen, H.M.G.
